Lepu Recognized As 'Leading Entity' for Fighting Against COVID-19

Recently, Beijing Lepu Medical Technology Co,.LTD., the major subsidiary of Lepu Medical, was recognized as a ''Leading Entity" by the Minstry of Industry and Information Technology of China, for actively fighting against COVID-19.

Since the breakout of the pandemic, Lepu has been taking efforts to input the manufacture of anti-COVID-19 products with its advanced R&D capability and IVD technology. In 2020, Lepu's various array of products-- SARS-CoV-2 Test Kit, SARS-CoV-2 Nucleic Acid Test Kit (PCR-Fluorescence Probe Method) and Infrared Forehead Themometers, were approved by the European Commission, making them available on the global market. In China, Lepu's PCR Solution has been widely used in hospital, testing centers, and centers for disease control.

Lepu Recognized As 'Leading Entity' for Fighting Against COVID-19

To support the soaring global medical needs, the researchers and staff of Lepu have been working hard to ensure the productivity and quality of the products. So far, Lepu has helped more than 140 countries to fight against COVID-19.

We are proud to receive the recognition, and as a responsible enterprise, we will endeavor to bring effective and high-quality products to back the humankind constantly!